Misonix Inc (MSON) SEC Filing 10-K Annual report for the fiscal year ending Tuesday, June 30, 2015

Exhibit 99.1

Misonix, Inc. Announces THIRD Quarter

Fiscal Year 2015 Financial Results 

Third Quarter Net Revenues UP 24%;

Nine Month Net Revenue UP 35%;

Third Quarter BoneScalpel^tm Revenue UP 27%;

FARMINGDALE, NY, May 7, 2015 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the third quarter of fiscal 2015, ended March 31, 2015.

Highlights for the third quarter fiscal 2015 included: 

• Net sales totaled $5.3 million, a 24% increase, compared to $4.3 million for the same period in fiscal 2014.
• BoneScalpel revenue worldwide increased 27% to $2.2 million versus $1.7 million in the third quarter of fiscal 2014.
• BoneScalpel units consigned in the United States during the third quarter fiscal 2015 totaled 27 compared to 13 systems; an increase of 108%. Total BoneScalpel units installed in the United States are 328.
• BoneScalpel revenue in the United States increased 36% to $1.2 million in the third quarter fiscal 2015 compared to $908,000 during third quarter fiscal 2014.
• SonaStar® revenue increased 30% to $2.0 million versus $1.6 million in the third quarter of fiscal 2014.
• SonaStar units sold worldwide in third quarter fiscal 2015 totaled 34 compared to 20 systems in the third quarter of fiscal 2014, a 70% increase.
• SonicOne domestic revenue totaled $823,000 for the third quarter of fiscal 2015 compared to $709,000 in the third quarter of 2014. SonicOne units consigned in the U.S. during the third quarter totaled 11.
• Recurring worldwide revenue – comprised of BoneScalpel, SonicOne and SonaStar disposables sales - totaled $3.0 million, or 57% of total third quarter fiscal 2015 revenue, compared to $2.4 million, or 56% for the same period in fiscal 2014.
• Domestic revenue for the third quarter of fiscal 2015 was $2.6 million compared to $2.3 million for the same period in fiscal 2014.

Third Quarter Fiscal 2015 Financial Results

Total revenue for the three months ended March 31, 2015 was $5.3 million, a 24% increase, when compared to $4.3 million for the same period in fiscal 2014. The increase was attributable to a 27% increase in BoneScalpel revenue to $2.2 million, a 30% increase in SonaStar revenue to $2.0 million and a 16% increase in SonicOne revenue to $847,000.